Sun Pharmaceutical Industries Ltd Announces US FDA Tentative Approval for Generic Stalevo(R)

October 1, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

MUMBAI, India--(BUSINESS WIRE)--Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary a tentative approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Orion’s Stalevo® tablets.

Twitter
LinkedIn
Facebook
Email
Print

Regulatory Asia

Food and Drug Administration (FDA)